The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ultravate
Halobetasol propionate · HALOBETASOL PROPIONATE .5 mg/g · Lotion · Topical · Lacer Pharma, LLC
NDC 73159-0008-60 · 1 BOTTLE in 1 CARTON / 59 g in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$2.9M
1,470 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for halobetasol propionate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Ferndale Laboratories, Inc.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA208183
- TE code
- —
- Approval date
- Nov 6, 2015
- Patents / exclusivity
- 1 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8962028 | Jun 19, 2033 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Halobetasol propionate (Lotion)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bausch Health US, LLC | HALOBETASOL PROPIONATE .1 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Coral Way Pharma, LLC | HALOBETASOL PROPIONATE .5 mg/g | Jul 15, 2026 | Sep 2, 2026 |
| Lacer Pharma, LLC | HALOBETASOL PROPIONATE .5 mg/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ultravate — NDC 73159-0008-60," retrieved September 3, 2026, https://drugdashboards.com/drug/73159000860.
Free to cite with attribution — see how the data is put together.